Hayes, Inc.
Sydney Bridge is an experienced health technology assessment writer currently serving as an Associate Research Analyst at Hayes, Inc. since June 2016, specializing in clinical genetic testing for somatic and germline diagnostics. Previously, Sydney worked as a Preimplantation Genetic Scientist at the Colorado Center for Reproductive Medicine, focusing on laboratory molecular genetic diagnostics, and served as a consultant at Sagemont Healthcare Advocates, assisting individuals in interpreting complex clinical test results. Earlier roles include consulting clinical scientist at McKesson Health Solutions, where Sydney contributed to the McKesson Diagnostics Exchange™, and Professional Research Assistant at Denver Genetics, providing molecular diagnoses for rare genetic diseases. Sydney holds a Master of Science in Genetics from the University of Kent and a Bachelor of Arts in Molecular, Cellular, and Developmental Biology from the University of Colorado Boulder.
This person is not in any offices
Hayes, Inc.
Achieving best patient outcomes by using proven medical technologies is the basis on which Hayes was founded. Our team of analysts and clinical informatics specialists is a trusted resource for unbiased and timely research, evidence analysis, and guidance that drive effective health technology utilization and cost management. For over 25 years, Hayes has been empowering clinicians, health plan policymakers, and government agencies in their mission to make sound evidence-based decisions that balance cost, quality and patient outcomes.